Evidence map›Paper›PMID 36466916›Full record

ArticleFrontiers in immunology2022

Monocyte adaptations in patients with obesity during a 1.5 year lifestyle intervention.

Eline S van der Valk, Daniël S Mulder, Tessa Kouwenhoven, Nicole M A Nagtzaam, Elisabeth F C van Rossum, Willem A Dik, Pieter J M Leenen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Observational
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Eline S van der ValkObesity Center Centrum Gezond Gewicht (CGG), Erasmus Medical Center (MC), University Medical Center Rotterdam, Rotterdam, Netherlands.
Daniël S MulderObesity Center Centrum Gezond Gewicht (CGG), Erasmus Medical Center (MC), University Medical Center Rotterdam, Rotterdam, Netherlands.
Tessa KouwenhovenObesity Center Centrum Gezond Gewicht (CGG), Erasmus Medical Center (MC), University Medical Center Rotterdam, Rotterdam, Netherlands.
Nicole M A NagtzaamOccupational Health and Lifestyle, VitAll, Rotterdam, Netherlands.
Elisabeth F C van RossumObesity Center Centrum Gezond Gewicht (CGG), Erasmus Medical Center (MC), University Medical Center Rotterdam, Rotterdam, Netherlands.
Willem A DikLaboratory Medical Immunology, Department of Immunology, Erasmus Medical Center (MC), University Medical Center Rotterdam, Rotterdam, Netherlands.
Pieter J M LeenenDepartment of Immunology, Erasmus Medical Center (MC), University Medical Center Rotterdam, Rotterdam, Netherlands.
Erasmus MC · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Obesity is associated with chronic, low-grade inflammation, which is reflected in altered peripheral blood monocyte characteristics. The aim of this study was to analyze the monocyte subset composition (classical (CM), intermediate (IM) and non-classical monocytes (NCM)), and their inflammatory marker profile (CD14, CD16, CD36, CD45, CD64, CD300e, HLA-DR) in individuals with obesity during a 1.5 year combined lifestyle intervention (CLI), comprising healthy nutrition, increased exercise and behavioral changes. Methods: We analyzed monocyte subset counts and immunophenotypes in 73 individuals with obesity, and associated these to baseline body mass index (BMI) and waist circumference (WC). The measurements were repeated after 10 weeks and at the end of the intervention (1.5 years). Results: Generally, monocyte subset counts were not associated to BMI or WC at baseline, neither did monocyte counts change during the 1.5 year CLI. Immunophenotypically, higher baseline BMI and WC were associated to lower CD14 and higher CD300e expression by all subsets. During CLI there were remarkable changes in marker profiles: expression of CD14, CD36, CD45 and CD64 significantly decreased in CM and IM, as did CD16 (IM and NCM) (p<0.05). CD300e initially decreased after 10 weeks, but increased sharply at 1.5 years (all subsets). We observed no consistent associations between changes in monocyte characteristics and anthropometric changes. Conclusion: A 1.5 year CLI in individuals with obesity mediates persistent immunophenotypic adaptations related to cellular activation in blood monocytes, whereas changes in subset distribution are limited. Lifestyle-induced changes in the inflammatory profile of monocytes differ from the 'less-severe-obesity'-phenotype, suggesting a novel, 'post-weight-loss' monocyte setpoint.

Indexed as

MonocytesObesityBody Mass IndexCD36 AntigensHumansInflammationLeukocyte CountReceptors, IgGWeight LossCD36 AntigensReceptors, IgGclassical monocytescombined lifestyle interventionintermediate monocytesmonocyte activation phenotypemonocytesnon-classical monocytesobesity

Identifiers

PMID36466916
PMCPMC9716348
OpenAlexW4309378740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.